A vitamin E long-chain metabolite and the inspired drug candidate α-amplexichromanol relieve asthma features in an experimental model of allergen sensitization - Université d'Angers Accéder directement au contenu
Article Dans Une Revue Pharmacological Research Année : 2022

A vitamin E long-chain metabolite and the inspired drug candidate α-amplexichromanol relieve asthma features in an experimental model of allergen sensitization

Ida Cerqua
  • Fonction : Auteur
Konstantin Neukirch
  • Fonction : Auteur
Michela Terlizzi
  • Fonction : Auteur
Elisabetta Granato
  • Fonction : Auteur
Elisabetta Caiazzo
  • Fonction : Auteur
Carla Cicala
  • Fonction : Auteur
Armando Ialenti
  • Fonction : Auteur
Raffaele Capasso
  • Fonction : Auteur
Oliver Werz
  • Fonction : Auteur
Rosalinda Sorrentino
  • Fonction : Auteur
Giuseppe Cirino
  • Fonction : Auteur
Andreas Koeberle
  • Fonction : Auteur
Fiorentina Roviezzo
  • Fonction : Auteur
Antonietta Rossi
  • Fonction : Auteur

Résumé

Benefits for vitamin E intake in diseases with inflammatory components have been described and related in part, to endogenously formed metabolites (long-chain metabolites, LCM). Here, we have evaluated the role of LCM in relieving asthma features. To this aim, the endogenous vitamin E metabolite α-13′-carboxychromanol (α-T-13′-COOH) that acts as potent 5-lipoxygenase inhibitor has been administered either intraperitoneally or by oral gavage to BALB/c mice sensitized by subcutaneous injection of ovalbumin (OVA). We also have taken advantage of the metabolically stable α-T-13′-COOH derivative α-amplexichromanol (α-AC). Intraperitoneal treatment with α-T-13'-COOH reduced OVA-induced airway hyperreactivity (AHR) as well as peri-bronchial inflammatory cell infiltration. α-AC was more efficacious than α-T-13'-COOH, as demonstrated by better control of AHR and in reducing subepithelial. Both compounds exerted their protective function by reducing pulmonary leukotriene C4 levels. Beneficial effects of α-AC were coupled to inhibition of the sensitization process, as indicated by a reduction of IgE plasma levels, lung mast cell infiltration and Th2 immune response. Metabololipidomics analysis revealed that α-AC raises the pulmonary levels of prostanoids, their degradation products, and 12/15-lipoxygenase metabolites. Following oral administration, the pharmacodynamically different profile in α-T-13′-COOH and α-AC was abrogated as demonstrated by a similar and improved efficacy in controlling asthma features as well as by metabololipidomics analysis. In conclusion, this study highlights a role for LCM and of vitamin E derivatives as pharmacologically active compounds that ameliorate asthmatic features and defines an important role for endogenous vitamin E metabolites in regulating immune response underlying the sensitization process.
Fichier principal
Vignette du fichier
Pharmacol res 2022.pdf (1.81 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03788166 , version 1 (22-09-2023)

Identifiants

Citer

Ida Cerqua, Konstantin Neukirch, Michela Terlizzi, Elisabetta Granato, Elisabetta Caiazzo, et al.. A vitamin E long-chain metabolite and the inspired drug candidate α-amplexichromanol relieve asthma features in an experimental model of allergen sensitization. Pharmacological Research, 2022, 181, pp.106250. ⟨10.1016/j.phrs.2022.106250⟩. ⟨hal-03788166⟩
8 Consultations
35 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More